Symbol="ARDX"
AssetType="Common Stock"
Name="Ardelyx Inc"
Description="Ardelyx, Inc., a biopharmaceutical company, develops and sells drugs for the treatment of kidney and cardiorenal diseases in the United States and internationally. The company is headquartered in Fremont, California."
CIK="1437402"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="34175 ARDENWOOD BLVD., FREMONT, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="727026000"
EBITDA="-54849000"
PERatio="None"
PEGRatio="-0.08"
BookValue="0.585"
DividendPerShare="0"
DividendYield="0"
EPS="-0.32"
RevenuePerShareTTM="0.355"
ProfitMargin="-1.045"
OperatingMarginTTM="-0.885"
ReturnOnAssetsTTM="-0.201"
ReturnOnEquityTTM="-0.695"
RevenueTTM="63059000"
GrossProfitTTM="15540000"
DilutedEPSTTM="-0.32"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="23.29"
AnalystTargetPrice="8.21"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="39.54"
PriceToBookRatio="5.52"
EVToRevenue="35.06"
EVToEBITDA="-2.879"
Beta="1.197"
num_52WeekHigh="5.12"
num_52WeekLow="0.632"
num_50DayMovingAverage="3.941"
num_200DayMovingAverage="2.937"
SharesOutstanding="214462000"
DividendDate="None"
ExDividendDate="None"
symbol="ARDX"
open="3.39"
high="3.39"
low="3.26"
price="3.31"
volume="4167553.00"
latest_trading_day="2023-07-06"
previous_close="3.40"
change="-0.09"
change_percent="-2.6471%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="26"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="74"
Volume_recent_avg="6658274"
Change_recent_avg="-0.01"
Delta_recent_avg="0.24"
Variance_recent_avg="0.12"
Change_ratio_recent_avg="-0.32"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="74"
Aroon_momentum_negative="26"
image_negative_thumbnail_id_1="1093"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0126.jpeg"
image_negative_thumbnail_id_2="105"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0071.jpeg"
image_neutral_thumbnail_id_1="590"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0009.jpeg"
image_neutral_thumbnail_id_2="554"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0045.jpeg"
image_positive_thumbnail_id_1="966"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0128.jpeg"
image_positive_thumbnail_id_2="616"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0092.jpeg"
image_professor_thumbnail_id_1="1169"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
image_professor_thumbnail_id_2="1178"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
